We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sodium‐glucose co‐transporter‐2 inhibitors and cardiovascular outcome studies in people with type 2 diabetes: From efficacy to effectiveness.
- Authors
Khunti, Kamlesh; Kosiborod, Mikhail
- Abstract
The article focuses on the higher risk of cardiovascular disease to diabetes type 2 patients. It discusses the therapeutic benefits of sodium-glucose co-transporter-2 (SGLT2) inhibitors and glucose lowering trials with pressure on the lowering glycated haemoglobin (HbA1c) and also talks about bad nephropathy and serum creatinine.
- Subjects
TYPE 2 diabetes complications; TYPE 2 diabetes risk factors; CARDIOVASCULAR diseases; SODIUM-glucose cotransporters; CREATININE
- Publication
Diabetes, Obesity & Metabolism, 2018, Vol 20, Issue 4, p763
- ISSN
1462-8902
- Publication type
Article
- DOI
10.1111/dom.13142